387 related articles for article (PubMed ID: 23132513)
41. [Pharmacokinetics of vancomycin in continuous veno-venous hemofiltration].
Gu Q; Zhu ZH; Ge M; Ge WH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):114-6. PubMed ID: 12857476
[TBL] [Abstract][Full Text] [Related]
42. Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.
Akers KS; Cota JM; Chung KK; Renz EM; Mende K; Murray CK
J Burn Care Res; 2012; 33(6):e254-62. PubMed ID: 22878490
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of separated system continuous venovenous hemofiltration in critical acute kidney injury.
Susantitaphong P; Tiranathanagul K; Srisawat N; Katavetin P; Praditpornsilpa K; Eiam-Ong S
Ther Apher Dial; 2011 Oct; 15(5):475-80. PubMed ID: 21974701
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.
Malone RS; Fish DN; Abraham E; Teitelbaum I
Antimicrob Agents Chemother; 2001 Nov; 45(11):3148-55. PubMed ID: 11600370
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
Guenter SG; Iven H; Boos C; Bruch HP; Muhl E
Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
[TBL] [Abstract][Full Text] [Related]
46. Augmented renal clearance in septic patients and implications for vancomycin optimisation.
Baptista JP; Sousa E; Martins PJ; Pimentel JM
Int J Antimicrob Agents; 2012 May; 39(5):420-3. PubMed ID: 22386742
[TBL] [Abstract][Full Text] [Related]
47. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
Tiranathanagul K; Jearnsujitwimol O; Susantitaphong P; Kijkriengkraikul N; Leelahavanichkul A; Srisawat N; Praditpornsilpa K; Eiam-Ong S
Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
[TBL] [Abstract][Full Text] [Related]
48. Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.
Masich AM; Kalaria SN; Gonzales JP; Heil EL; Tata AL; Claeys KC; Patel D; Gopalakrishnan M
Pharmacotherapy; 2020 Mar; 40(3):211-220. PubMed ID: 31957057
[TBL] [Abstract][Full Text] [Related]
49. Effects of different doses in continuous veno-venous hemofiltration on plasma lactate in critically ill patients.
Liu Y; Ouyang B; Chen J; Chen M; Ma J; Wu J; Huang S; Li L; Liu Z; Guan X
Chin Med J (Engl); 2014; 127(10):1827-32. PubMed ID: 24824239
[TBL] [Abstract][Full Text] [Related]
50. Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.
Radke C; Horn D; Lanckohr C; Ellger B; Meyer M; Eissing T; Hempel G
Clin Pharmacokinet; 2017 Jul; 56(7):759-779. PubMed ID: 28039606
[TBL] [Abstract][Full Text] [Related]
51. Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients.
Ocampos-Martinez E; Penaccini L; Scolletta S; Abdelhadii A; Devigili A; Cianferoni S; de Backer D; Jacobs F; Cotton F; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2012 Apr; 39(4):332-7. PubMed ID: 22333933
[TBL] [Abstract][Full Text] [Related]
52. Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration.
Wenisch JM; Meyer B; Fuhrmann V; Saria K; Zuba C; Dittrich P; Thalhammer F
J Antimicrob Chemother; 2012 Apr; 67(4):977-83. PubMed ID: 22210754
[TBL] [Abstract][Full Text] [Related]
53. Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study.
Markou N; Fousteri M; Markantonis SL; Zidianakis B; Hroni D; Boutzouka E; Baltopoulos G
J Antimicrob Chemother; 2012 Oct; 67(10):2459-62. PubMed ID: 22790220
[TBL] [Abstract][Full Text] [Related]
54. Pilot Study of the Pharmacokinetics of Cefotaxime in Critically Ill Patients with Acute Kidney Injury Treated with Continuous Renal Replacement Therapy.
Koedijk JB; Valk-Swinkels CG; Rijpstra TA; Touw DJ; Mulder PG; van der Voort PH; van 't Veer NE; van der Meer NJ
Antimicrob Agents Chemother; 2016 Jun; 60(6):3587-90. PubMed ID: 27021325
[TBL] [Abstract][Full Text] [Related]
55. Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients.
Denetclaw TH; Dowling TC; Steinke D
Ann Pharmacother; 2013 Dec; 47(12):1611-7. PubMed ID: 24259632
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
[TBL] [Abstract][Full Text] [Related]
57. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Lefrant JY; Roberts JA
Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279
[TBL] [Abstract][Full Text] [Related]
58. Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.
Lee B; Kim SJ; Park JD; Park J; Jung AH; Jung SH; Choi YH; Kang HG; Ha IS; Cheong HI
PLoS One; 2018; 13(6):e0199158. PubMed ID: 29927988
[TBL] [Abstract][Full Text] [Related]
59. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
[TBL] [Abstract][Full Text] [Related]
60. A Practice-Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE-01).
Kalaria SN; Armahizer M; McCarthy P; Badjatia N; Gobburu JV; Gopalakrishnan M
Clin Transl Sci; 2020 Sep; 13(5):950-959. PubMed ID: 32223067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]